|
|
|
|
Office Locations:
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
CVS Health Ventures is a dedicated corporate venture capital fund that works with high-potential, early-stage companies focused on making health care more accessible, affordable and simpler. CVS focuses on investments that support the overall vision and strategy of CVS Health: Transforming care delivery, Whole person care, Consumer-centric health, and Disruptive technology enablement. According to published reports, the CVS Health Ventures launched with a $100 million fund.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
|
| Alyssa Reisner | |
| |
Lead Director and Investment Principal | |
| Vijay Patel | |
| |
Managing Partner | |
|
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
09/25/2025
|
Thyme Care
|
TN
|
$97,000,000
|
Series D
|
09/23/2025
|
AmplifAI
|
TX
|
$33,700,000
|
Series B
|
09/09/2025
|
Strive Health
|
CO
|
$550,000,000
|
Venture Debt & Equity
|
07/22/2025
|
AbsoluteCare
|
MD
|
$135,000,000
|
Venture
|
06/13/2025
|
Ellipsis Health
|
CA
|
$45,000,000
|
Series A
|
02/06/2025
|
Lynx
|
MA
|
$27,000,000
|
Series A
|
|
|
|
|
|
|
|
